Researchers provide consensus recommendations on managing selected comorbidities in rheumatoid arthritis
Researchers validate the role of serum biomarkers in determining disease activity of ANCA-associated vasculitis
Favorable benefit-risk ratio of upadacitinib compared to adalimumab for managing moderate-to severe RA
You must be logged in to post a comment.